Clinical Trial Update: Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two doses of desmopressin orally lyophilisate tablet for nocturnal enuresis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Desmopressin Acetate (Orally Lyophilisate Tablet) (desmopressin acetate)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturnal Enuresis | Phase 3 | Status: COMPLETED | Results posted: 2011-11-02